Rafael Dal-Ré (Rafael Dal Re, R Dal-Ré)

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 46

Top Topics

Respiratory Syndrome Coronavirus

Placebo Controlled

Top Venues

European journal of clinical pharmacology

European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology

British journal of clinical pharmacology

European journal of clinical investigation

This page only lists publications with an associated author ORCID identifier.

Publications

Rafael Dal-Ré
Is "interventional trial" a correct term to use in clinical research? European journal of clinical pharmacology 80 (7) (2024)
Rafael Dal-Ré, Emmanuel Bottieau, Odile Launay, Frits R Rosendaal, Brigitte Schwarzer-Daum
Challenges in conducting efficacy trials for new COVID-19 vaccines in developed countries. Clinical trials (London, England) (2024)
Rafael Dal-Ré
Current policies of non-commercial funders towards transparency in clinical trials. European journal of clinical investigation (2024)
Rafael Dal-Ré
Is "interventional trial" a correct term to use in clinical research? European journal of clinical pharmacology (2024)
Rafael Dal-Ré, Ignacio Mahillo Fernández
Principal Features of Industry-Funded Trials that Posted Informed Consent Forms on ClinicalTrials.gov: a Cross-Sectional Analysis. The AAPS journal 26 (4) (2024)
Rafael Dal-Ré, Ignacio Mahillo Fernández
Principal Features of Industry-Funded Trials that Posted Informed Consent Forms on ClinicalTrials.gov: a Cross-Sectional Analysis. The AAPS journal 26 (4) (2024)
Rafael Dal-Ré
Current policies of non-commercial funders towards transparency in clinical trials. European journal of clinical investigation 54 (6) (2024)
Rafael Dal-Ré, Ignacio Mahillo Fernández
Principal Features of Industry-Funded Trials that Posted Informed Consent Forms on ClinicalTrials.gov: a Cross-Sectional Analysis. The AAPS journal 26 (4) (2024)
Rafael Dal-Ré, Arthur L Caplan, Søren Holm, Reecha Sofat, Richard Stephens
Adequate information about clinical trial results must be given to participants. Nature medicine (2024)
Rafael Dal-Ré, Ana Marusic
The definition of research misconduct should be stated in the abstract when reporting research on research misconduct. Accountability in research (2024)
Rafael Dal-Ré
Is it reasonable to label a trial as pragmatic whose investigatorsdo not? The UK RECOVERY COVID-19 trial case. Clinical trials (London, England) (2023)
Rafael Dal-Ré
Waivers of informed consent in research with competent participants and the Declaration of Helsinki. European journal of clinical pharmacology 79 (4) (2023)
Rafael Dal-Ré, Stefan K James
Is the TIME study on antihypertensive therapy and chronotropic effects on cardiovascular outcomes a pragmatic trial? European heart journal. Cardiovascular pharmacotherapy (2023)
Rafael Dal-Ré
Waivers of informed consent in research with competent participants and the Declaration of Helsinki. European journal of clinical pharmacology 79 (4) (2023)
Rafael Dal-Ré
Is it reasonable to label a trial as pragmatic whose investigatorsdo not? The UK RECOVERY COVID-19 trial case. Clinical trials (London, England) (2023)
Rafael Dal-Ré
Waivers of informed consent in research with competent participants and the Declaration of Helsinki. European journal of clinical pharmacology (2023)
Rafael Dal-Ré
Waivers of informed consent in research with competent participants and the Declaration of Helsinki. European journal of clinical pharmacology (2023)
Rafael Dal-Ré, Søren Holm
Ethical concern regarding the UK PANORAMIC COVID-19 trial. British journal of clinical pharmacology 88 (7) (2022)
Rafael Dal-Ré, Christina Calvo, Marta Aboza Garcia
Off-label prescription of BNT162b2 mRNA COVID-19 vaccine to <5-year-old children in the European Union. Acta paediatrica (Oslo, Norway : 1992) (2022)
Soren Holm, Jonathan Lewis, Rafael Dal-Ré
Equipoise, standard of care and consent: responding to the authorisation of new COVID-19 treatments in randomised controlled trials. Journal of medical ethics (2022)
Rafael Dal-Ré, Sören Leif Becker, Odile Launay, Androula Pavli
Vaccine certificates for international travelers in future pandemics. European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 42 (2) (2022)
Rafael Dal-Ré
COVID-19 drug research and the cohort multiple randomised controlled trial design. The European respiratory journal 60 (3) (2022)
Rafael Dal-Ré, Sören Leif Becker, Odile Launay, Androula Pavli
Vaccine certificates for international travelers in future pandemics. European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology (2022)
Rafael Dal-Ré, Sören Leif Becker, Odile Launay, Androula Pavli
Vaccine certificates for international travelers in future pandemics. European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 42 (2) (2022)
Rafael Dal-Ré, Sören Leif Becker, Odile Launay, Androula Pavli
Vaccine certificates for international travelers in future pandemics. European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 42 (2) (2022)
Rafael Dal-Ré, Sören Leif Becker, Odile Launay, Androula Pavli
Vaccine certificates for international travelers in future pandemics. European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology (2022)
Rafael Dal-Ré
Single research ethics committee review for multinational trials is a misconception. Journal of the Royal Society of Medicine 115 (2) (2022)
Rafael Dal-Ré
Will AstraZeneca be able to provide clinical trial data on its COVID-19 vaccine efficacy in older adults? British journal of clinical pharmacology 87 (5) (2021)
Rafael Dal-Ré
Clinical Equipoise in COVID-19 Vaccine Candidate Trials. Journal of clinical pharmacology 61 (9) (2021)
Rafael Dal-Ré
Placebo control group in COVID-19 vaccine trials: context and timing matters. European journal of clinical pharmacology (2021)
Rafael Dal-Ré, Walter Orenstein, Arthur L Caplan
Being fair to participants in placebo-controlled COVID-19 vaccine trials. Nature medicine 27 (6) (2021)
Rafael Dal-Ré, Robert J Mentz, Frits R Rosendaal
Thoughtful selection and use of scientific terms in clinical research: the case of 'pragmatic' trials. Journal of investigative medicine : the official publication of the American Federation for Clinical Research 69 (5) (2021)
Rafael Dal-Ré
Pragmatic trials, blinding, placebos, and the usefulness of the PRECIS-2 tool. European journal of clinical pharmacology 77 (7) (2021)
Trevor Torgerson, Cole Wayant, Lisa Cosgrove, Elie A Akl, Jake Checketts, Rafael Dal-Ré, Jennifer Gill, Samir C Grover, Nasim Khan, Rishad Khan, Ana Marušić, Matthew S McCoy, Aaron Mitchell, Vinay Prasad, Matt Vassar
Ten years later: a review of the US 2009 institute of medicine report on conflicts of interest and solutions for further reform. BMJ evidence-based medicine (2020)
Rafael Dal-Ré, Arthur L Caplan, Christian Gluud, Raphael Porcher
Ethical and Scientific Considerations Regarding the Early Approval and Deployment of a COVID-19 Vaccine. Annals of internal medicine 174 (2) (2020)
Rafael Dal-Ré
The PRECIS-2 tool seems not to be useful to discriminate the degree of pragmatism of medicine masked trials from that of open-label trials. European journal of clinical pharmacology 77 (4) (2020)
Rafael Dal-Ré, Raphaël Porcher, Christian Gluud
COVID-19 clinical trials: Ethical and scientific consequences of the RECOVERY trial results. Basic & clinical pharmacology & toxicology 127 (6) (2020)
Rafael Dal-Ré
Unperceived similarities between clinical trials and quantum physics. British journal of clinical pharmacology 86 (2) (2020)
Rafael Dal-Ré
Articles provided insufficient information to conduct an appropriate retrospective assessment of the pragmatic/explanatory features of medicine trials with the PRECIS-2 tool. European journal of clinical pharmacology 76 (8) (2020)
Rafael Dal-Ré, Carmen Ayuso
Reasons for and time to retraction of genetics articles published between 1970 and 2018. Journal of medical genetics 56 (11) (2019)
Rafael Dal-Ré
On the semantics of clinical trials. The case of a 'pragmatic' trial in Alzheimer's disease. European journal of neurology 27 (3) (2019)
Rafael Dal-Ré
Plan S: Funders are committed to open access to scientific publication. European journal of clinical investigation (2019)
Rafael Dal-Ré
The misleading use of the term pragmatic in pre-licensing medicine trials. European journal of clinical pharmacology 75 (8) (2019)
Rafael Dal-Ré
Analysis of retracted articles on medicines administered to humans. British journal of clinical pharmacology 85 (9) (2019)
Rafael Dal-Ré, Arthur L Caplan, Ana Marusic
Editors' and authors' individual conflicts of interest disclosure and journal transparency. A cross-sectional study of high-impact medical specialty journals. BMJ open 9 (7) (2019)
Rafael Dal-Ré
Could phase 3 medicine trials be tagged as pragmatic? A case study: The Salford COPD trial. Journal of evaluation in clinical practice 24 (1) (2017)